Note 17 - Reportable Segments - Reportable Segments (Details) - USD ($) | 3 Months Ended | 9 Months Ended |
Sep. 30, 2016 | Sep. 30, 2015 | Sep. 30, 2016 | Sep. 30, 2015 |
Operating Segments [Member] | Display Technologies [Member] | | | | | |
Net sales | | $ 902,000,000 | $ 757,000,000 | $ 2,408,000,000 | $ 2,354,000,000 |
Depreciation | [1] | 152,000,000 | 147,000,000 | 452,000,000 | 455,000,000 |
Amortization of purchased intangibles | | 0 | 0 | 0 | 0 |
Research, development and engineering expenses | [2] | 14,000,000 | 28,000,000 | 49,000,000 | 78,000,000 |
Equity in earnings of affiliated companies | | 0 | (3,000,000) | 0 | (8,000,000) |
Income tax (provision) benefit | | (98,000,000) | (119,000,000) | (277,000,000) | (387,000,000) |
Net income | [3] | 279,000,000 | 255,000,000 | 692,000,000 | 852,000,000 |
Restructuring, impairment and other charges | | | | 4,000,000 | |
Operating Segments [Member] | Optical Communications [Member] | | | | | |
Net sales | | 795,000,000 | 747,000,000 | 2,186,000,000 | 2,244,000,000 |
Depreciation | [1] | 41,000,000 | 41,000,000 | 125,000,000 | 122,000,000 |
Amortization of purchased intangibles | | 10,000,000 | 7,000,000 | 25,000,000 | 24,000,000 |
Research, development and engineering expenses | [2] | 37,000,000 | 33,000,000 | 110,000,000 | 101,000,000 |
Equity in earnings of affiliated companies | | 0 | 0 | 0 | 0 |
Income tax (provision) benefit | | (49,000,000) | (34,000,000) | (99,000,000) | (100,000,000) |
Net income | [3] | 78,000,000 | 70,000,000 | 172,000,000 | 204,000,000 |
Restructuring, impairment and other charges | | | | 6,000,000 | |
Operating Segments [Member] | Environmental Technologies [Member] | | | | | |
Net sales | | 264,000,000 | 257,000,000 | 787,000,000 | 799,000,000 |
Depreciation | [1] | 32,000,000 | 32,000,000 | 97,000,000 | 93,000,000 |
Amortization of purchased intangibles | | 0 | 0 | 0 | 0 |
Research, development and engineering expenses | [2] | 24,000,000 | 21,000,000 | 75,000,000 | 67,000,000 |
Equity in earnings of affiliated companies | | 0 | 0 | 0 | 0 |
Income tax (provision) benefit | | (17,000,000) | (19,000,000) | (52,000,000) | (64,000,000) |
Net income | [3] | 35,000,000 | 38,000,000 | 106,000,000 | 132,000,000 |
Restructuring, impairment and other charges | | | | 5,000,000 | |
Operating Segments [Member] | Specialty Materials [Member] | | | | | |
Net sales | | 295,000,000 | 288,000,000 | 788,000,000 | 832,000,000 |
Depreciation | [1] | 26,000,000 | 29,000,000 | 81,000,000 | 82,000,000 |
Amortization of purchased intangibles | | 0 | 0 | 0 | 0 |
Research, development and engineering expenses | [2] | 31,000,000 | 27,000,000 | 96,000,000 | 87,000,000 |
Equity in earnings of affiliated companies | | 0 | 0 | 0 | 0 |
Income tax (provision) benefit | | (21,000,000) | (23,000,000) | (52,000,000) | (66,000,000) |
Net income | [3] | 42,000,000 | 46,000,000 | 106,000,000 | 128,000,000 |
Restructuring, impairment and other charges | | | | 12,000,000 | |
Operating Segments [Member] | Life Sciences [Member] | | | | | |
Net sales | | 214,000,000 | 211,000,000 | 633,000,000 | 619,000,000 |
Depreciation | [1] | 14,000,000 | 15,000,000 | 42,000,000 | 45,000,000 |
Amortization of purchased intangibles | | 5,000,000 | 5,000,000 | 15,000,000 | 15,000,000 |
Research, development and engineering expenses | [2] | 6,000,000 | 6,000,000 | 18,000,000 | 17,000,000 |
Equity in earnings of affiliated companies | | 0 | 0 | 0 | |
Income tax (provision) benefit | | (8,000,000) | (9,000,000) | (22,000,000) | (26,000,000) |
Net income | [3] | 16,000,000 | 18,000,000 | 45,000,000 | 52,000,000 |
Restructuring, impairment and other charges | | | | 3,000,000 | |
Operating Segments [Member] | Other Segments [Member] | | | | | |
Net sales | | 37,000,000 | 12,000,000 | 112,000,000 | 32,000,000 |
Depreciation | [1] | 12,000,000 | 9,000,000 | 34,000,000 | 29,000,000 |
Amortization of purchased intangibles | | 2,000,000 | 0 | 6,000,000 | 0 |
Research, development and engineering expenses | [2] | 47,000,000 | 34,000,000 | 139,000,000 | 123,000,000 |
Equity in earnings of affiliated companies | | (3,000,000) | 4,000,000 | (8,000,000) | 12,000,000 |
Income tax (provision) benefit | | 21,000,000 | 19,000,000 | 87,000,000 | 63,000,000 |
Net income | [3] | (47,000,000) | (38,000,000) | (187,000,000) | (131,000,000) |
Restructuring, impairment and other charges | | | | 40,000,000 | |
Operating Segments [Member] | | | | | |
Net sales | | 2,507,000,000 | 2,272,000,000 | 6,914,000,000 | 6,880,000,000 |
Depreciation | [1] | 277,000,000 | 273,000,000 | 831,000,000 | 826,000,000 |
Amortization of purchased intangibles | | 17,000,000 | 12,000,000 | 46,000,000 | 39,000,000 |
Research, development and engineering expenses | [2] | 159,000,000 | 149,000,000 | 487,000,000 | 473,000,000 |
Equity in earnings of affiliated companies | | (3,000,000) | 1,000,000 | (8,000,000) | 4,000,000 |
Income tax (provision) benefit | | (172,000,000) | (185,000,000) | (415,000,000) | (580,000,000) |
Net income | [3] | 403,000,000 | 389,000,000 | 934,000,000 | 1,237,000,000 |
Restructuring, impairment and other charges | | | | 70,000,000 | |
Display Technologies [Member] | | | | | |
Restructuring, impairment and other charges | | | | 4,000,000 | |
Optical Communications [Member] | | | | | |
Restructuring, impairment and other charges | | | | 6,000,000 | |
Environmental Technologies [Member] | | | | | |
Restructuring, impairment and other charges | | | | 5,000,000 | |
Specialty Materials [Member] | | | | | |
Restructuring, impairment and other charges | | | | 12,000,000 | |
Life Sciences [Member] | | | | | |
Restructuring, impairment and other charges | | | | 3,000,000 | |
Other Segments [Member] | | | | | |
Restructuring, impairment and other charges | | | | 40,000,000 | |
Net sales | | 2,507,000,000 | 2,272,000,000 | 6,914,000,000 | 6,880,000,000 |
Depreciation | | | | 844,000,000 | 842,000,000 |
Amortization of purchased intangibles | | 17,000,000 | 12,000,000 | 46,000,000 | 40,000,000 |
Research, development and engineering expenses | | 187,000,000 | 181,000,000 | 569,000,000 | 561,000,000 |
Equity in earnings of affiliated companies | | 19,000,000 | 39,000,000 | 119,000,000 | 195,000,000 |
Income tax (provision) benefit | | 27,000,000 | (6,000,000) | 835,000,000 | (202,000,000) |
Net income | | 284,000,000 | 212,000,000 | 2,123,000,000 | 1,115,000,000 |
Restructuring, impairment and other charges | | $ 0 | $ 0 | $ 78,000,000 | $ 0 |
| |
[1] | Depreciation expense for Corning's reportable segments includes an allocation of depreciation of corporate property not specifically identifiable to a segment. | |
[2] | Research, development and engineering expenses include direct project spending that is identifiable to a segment. | |
[3] | Many of Corning's administrative and staff functions are performed on a centralized basis. Where practicable, Corning charges these expenses to segments based upon the extent to which each business uses a centralized function. Other staff functions, such as corporate finance, human resources and legal, are allocated to segments, primarily as a percentage of sales. Expenses that are not allocated to the segments are included in the reconciliation of reportable net segment net income to consolidated net income below. | |